Oxidative Stress Promotes Transcriptional Up-regulation of Fyn in BCR-ABL1-expressing Cells

Por Gao, Yin, Howard, Adrienne, Ban, Kechen, Chandra, Joya
Publicado em 2009

Expression and Activity of Fyn Mediate Proliferation and Blastic Features of Chronic Myelogenous Leukemia

Por Singh, Melissa M., Howard, Adrienne, Irwin, Mary E., Gao, Yin, Lu, Xiaolin, Multani, Asha, Chandra, Joya
Publicado em 2012

BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia

Por Ban, Kechen, Gao, Yin, Amin, Hesham M., Howard, Adrienne, Miller, Claudia, Lin, Quan, Leng, Xiaohong, Munsell, Mark, Bar-Eli, Menashe, Arlinghaus, Ralph B., Chandra, Joya
Publicado em 2008

Barriers to Study Enrollment in Patients With Advanced Cancer Referred to a Phase I Clinical Trials Unit

Por Fu, Siqing, McQuinn, Lacey, Naing, Aung, Wheler, Jennifer J., Janku, Filip, Falchook, Gerald S., Piha-Paul, Sarina A., Tu, Dennis, Howard, Adrienne, Tsimberidou, Apostolia, Zinner, Ralph, Hong, David S., Kurzrock, Razelle
Publicado em 2013

Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: A phase I trial of bortezomib plus bevacizumab

Por Falchook, Gerald S, Wheler, Jennifer J, Naing, Aung, Jackson, Edward F, Janku, Filip, Hong, David, Ng, Chaan S, Tannir, Nizar M, Lawhorn, Kristie N, Huang, Mei, Angelo, Laura S, Vishwamitra, Deeksha, Hess, Kenneth, Howard, Adrienne N, Parkhurst, Kristin L, Amin, Hesham M, Kurzrock, Razelle
Publicado no Oncotarget (2014)

Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer

Por Fu, Siqing, Hennessy, Bryan T., Ng, Chaan S., Ju, Zhenlin, Coombes, Kevin R., Wolf, Judith K., Sood, Anil K., Levenback, Charles F., Coleman, Robert L., Kavanagh, John J., Gershenson, David M., Markman, Maurie, Dice, Kristine, Howard, Adrienne, Li, Jane, Li, Yang, Stemke-Hale, Katherine, Dyer, Mary, Atkinson, Edward, Jackson, Ed, Kundra, Vikas, Kurzrock, Razelle, Bast, Robert C., Mills, Gordon B.
Publicado em 2012